Kamada
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- -
- Employees
- 378
- Market Cap
- $326M
- Introduction
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, ...
Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency
Phase 2
Completed
- Conditions
- First Posted Date
- 2007-04-13
- Last Posted Date
- 2007-10-17
- Lead Sponsor
- Kamada, Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT00460096
- Locations
- 🇺🇸
National Jewish Medical and Research Center, Denver, Colorado, United States
🇺🇸University of Florida School of Medicine, Gainesville, Florida, United States
🇺🇸The University of Texas Health Center at Tyler, Tyler, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath